← Leaderboards
Hongjun Wang
Ralph H Johnson Va Medical Center
$13,230,625
Attributed
$13,230,625
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,230,625 · 9
VA$0 · 2
By mechanism
R01$11,151,009 · 4
R21$822,250 · 2
UH3$782,554 · 1
UG3$327,555 · 1
R03$147,257 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Infusion Procedures”
- Myron S Cohen · Family Health International$91,263,426
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
- Georgia D Tomaras · Fred Hutchinson Cancer Center$70,233,271
- Dan H. Barouch · Fred Hutchinson Cancer Center$63,804,365
- Lawrence Corey · Fred Hutchinson Cancer Center$58,962,452
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,962,452
Research focus
Infusion ProceduresInflammatoryClinical TrialsChronic PancreatitisCellsInsulin-Dependent Diabetes MellitusIsletMesenchymal Stem CellsCell DeathAllogenicDiabetes MellitusInsulinFunctional DisorderBeta CellImmuneCell PhysiologyHarvestMouse ModelInjuryPancreasTranslatingIslet CellCyclic GmpAutologous
Grant awards (38)
Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients$640,791
R01 · FY2025 · DK · contact PI
Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells$633,812
R01 · FY2025 · DK · contact PI
Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Chronic Pancreatitis and Its Associated Pain$395,369
UH3 · FY2025 · DK · contact PI
Novel Cellular Therapy for the treatment of pain associated with chronic pancreatitis$0
I01 · FY2025 · VA · contact PI
hAAT-engineered Mesenchymal Stem Cells for the Treatment of Chronic Pain$0
I01 · FY2025 · VA · contact PI
Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients$615,158
R01 · FY2024 · DK · contact PI
Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells$612,705
R01 · FY2024 · DK · contact PI
Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Chronic Pancreatitis and Its Associated Pain$387,185
UH3 · FY2024 · DK · contact PI
Novel Cellular Therapy for the treatment of pain associated with chronic pancreatitis$0
I01 · FY2024 · VA · contact PI
Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients$640,791
R01 · FY2023 · DK · contact PI
Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells$628,557
R01 · FY2023 · DK · contact PI
Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Chronic Pancreatitis and Its Associated Pain$327,555
UG3 · FY2023 · DK · contact PI
hAAT-engineered Mesenchymal Stem Cells for the Treatment of Chronic Pain$0
I01 · FY2023 · VA · contact PI
Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients$640,791
R01 · FY2022 · DK · contact PI
Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells$628,036
R01 · FY2022 · DK · contact PI
hAAT-engineered Mesenchymal Stem Cells for the Treatment of Chronic Pain$0
I01 · FY2022 · VA · contact PI
Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients$632,231
R01 · FY2021 · DK · contact PI
Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells$630,957
R01 · FY2021 · DK · contact PI
Novel Gene and Stem Cell Therapy for Type 1 Diabetes$523,932
R01 · FY2021 · DK · contact PI
hAAT-engineered Mesenchymal Stem Cells for the Treatment of Chronic Pain$0
I01 · FY2021 · VA · contact PI
Novel Gene and Stem Cell Therapy for Type 1 Diabetes$529,169
R01 · FY2020 · DK · contact PI
Alpha1 Anti-trypsin Enhances Islet Autograft Survival$496,469
R01 · FY2020 · DK · contact PI
hAAT-engineered Mesenchymal Stem Cells for the Treatment of Chronic Pain$0
I01 · FY2020 · VA · contact PI
Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells$715,781
R01 · FY2019 · DK · contact PI
Novel Gene and Stem Cell Therapy for Type 1 Diabetes$548,629
R01 · FY2019 · DK · contact PI
Alpha1 Anti-trypsin Enhances Islet Autograft Survival$336,375
R01 · FY2019 · DK · contact PI
Alpha1 Anti-trypsin Enhances Islet Autograft Survival$98,670
R01 · FY2019 · DK · contact PI
Novel Gene and Stem Cell Therapy for Type 1 Diabetes$553,150
R01 · FY2018 · DK · contact PI
Alpha1 Anti-trypsin Enhances Islet Autograft Survival$336,375
R01 · FY2018 · DK · contact PI
Alpha1 Anti-trypsin Enhances Islet Autograft Survival$35,880
R01 · FY2018 · DK · contact PI
Alpha1 Anti-trypsin Enhances Islet Autograft Survival$336,375
R01 · FY2017 · DK · contact PI
Alpha1 Anti-trypsin Enhances Islet Autograft Survival$336,375
R01 · FY2016 · DK · contact PI
A Novel Approach to Prevent Surgical Diabetes in Chronic Pancreatitis Patients$186,875
R21 · FY2015 · DK · contact PI
A Novel Approach to Prevent Surgical Diabetes in Chronic Pancreatitis Patients$224,250
R21 · FY2014 · DK · contact PI
Islet and Mesenchymal Stem Cell Co-transplantation Prevents Onset of Diabetes$186,875
R21 · FY2014 · DK · contact PI
Novel Strategies to Increase Insulin Independence after Islet Autotransplantation$72,507
R03 · FY2014 · EB · contact PI
Islet and Mesenchymal Stem Cell Co-transplantation Prevents Onset of Diabetes$224,250
R21 · FY2013 · DK · contact PI
Novel Strategies to Increase Insulin Independence after Islet Autotransplantation$74,750
R03 · FY2013 · EB · contact PI